Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.

Russkamp, Norman F

Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin. [electronic resource] - FASEB journal : official publication of the Federation of American Societies for Experimental Biology Sep 2015 - 3762-72 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1530-6860

10.1096/fj.15-271635 doi


Acute Lung Injury--drug therapy
Animals
CCR5 Receptor Antagonists--pharmacology
Complement Activation
Complement C3a--genetics
Complement C5a, des-Arginine--genetics
Cyclohexanes--pharmacology
Leukocytes--metabolism
MAP Kinase Kinase 1--genetics
MAP Kinase Kinase 2--genetics
Maraviroc
Mice
Mice, Knockout
Phosphatidylinositol 3-Kinases--genetics
Proto-Oncogene Proteins c-akt--genetics
Pulmonary Alveoli--metabolism
Receptor, Anaphylatoxin C5a--genetics
Receptors, CCR5--genetics
Triazoles--pharmacology